A groundbreaking partnership between the Irish Cancer Society and Beaumont RCSI Cancer Centre has launched a €4.9 million initiative to revolutionize lung cancer treatment and research in Ireland.
The ambitious project targets lung cancer, which claims more Irish lives annually than breast, prostate, and colorectal cancer combined, earning it the grim distinction of being the country’s deadliest cancer.
According to The Irish Examiner, this collaboration represents one of the largest targeted investments in lung cancer research in Irish history, marking a significant step forward in the fight against this devastating disease.